Notes
Affiliated with Zogenix International.
Reference
Weston G, et al. A Cost-Effectiveness Analysis of Fenfluramine for the Treatment of Seizures for Patients with Dravet Syndrome (DS) in the UK Setting. 26th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research : abstr. PND33, 17 May 2021. Available from: URL: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2021-3340/109991
Rights and permissions
About this article
Cite this article
Add-on fenfluramine cost effective in patients with Dravet Syndrome in the UK. PharmacoEcon Outcomes News 880, 2 (2021). https://doi.org/10.1007/s40274-021-7760-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7760-6